Drug: PROLIA Injury: Neoplasm malignant Quarter: 2016Q3
Total Records: 34 Number of Pages: 2
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 122620594 | PROLIA | Neoplasm malignant | AMGEN | 68.00 YR | F | 0 | 20160714 | US |
| 123541062 | PROLIA | Neoplasm malignant | AMGEN | 58.00 YR | F | 0 | 20160823 | US |
| 125195661 | PROLIA | Neoplasm malignant | AMGEN | 83.00 YR | 0 | 20160701 | US | |
| 125204651 | PROLIA | Neoplasm malignant | AMGEN | 0.00 | F | 0 | 20160701 | IE |
| 125256561 | PROLIA | Neoplasm malignant | AMGEN | 83.00 YR | M | 0 | 20160705 | CA |
| 125303731 | PROLIA | Neoplasm malignant | AMGEN | 66.00 YR | F | 0 | 20160706 | CA |
| 125401771 | PROLIA | Neoplasm malignant | AMGEN | 0.00 | F | 0 | 20160708 | US |
| 125549792 | PROLIA | Neoplasm malignant | AMGEN | 69.00 YR | 0 | 20160912 | US | |
| 125613811 | PROLIA | Neoplasm malignant | AMGEN | 77.00 YR | F | 0 | 20160715 | CA |
| 125637931 | PROLIA | Neoplasm malignant | AMGEN | 61.00 YR | F | 0 | 20160716 | US |
| 125693491 | PROLIA | Neoplasm malignant | AMGEN | 0.00 | F | 0 | 20160719 | CA |
| 125856092 | PROLIA | Neoplasm malignant | AMGEN | 68.00 YR | F | 63 KG | 20160811 | CA |
| 126018681 | PROLIA | Neoplasm malignant | AMGEN | 0.00 | 0 | 20160728 | US | |
| 126262281 | PROLIA | Neoplasm malignant | AMGEN | 82.00 YR | F | 0 | 20160805 | US |
| 126463921 | PROLIA | Neoplasm malignant | AMGEN | 0.00 | 0 | 20160812 | US | |
| 126580711 | PROLIA | Neoplasm malignant | AMGEN | 0.00 | F | 0 | 20160817 | CA |
| 126584521 | PROLIA | Neoplasm malignant | AMGEN | 0.00 | F | 0 | 20160817 | US |
| 126625751 | PROLIA | Neoplasm malignant | AMGEN | 73.00 YR | F | 0 | 20160818 | US |
| 126685841 | PROLIA | Neoplasm malignant | AMGEN | 0.00 | F | 0 | 20160819 | MX |
| 126698531 | PROLIA | Neoplasm malignant | AMGEN | 88.00 YR | F | 0 | 20160820 | CA |
Total Records: 34 Number of Pages: 2